Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - REVENUE
Revenue EYPT - EyePoint Pharmaceuticals, Inc.
46 M
LAST VALUE
11.61%
2 YEAR CAGR
73.10%
5 YEAR CAGR
35.89%
10 YEAR CAGR